Morgan Wilson

Background

About Morgan Wilson

Associate Director with extensive background in biochemical, immunological, and bioassay development with a demonstrated expertise in cell based bioassay development. Experienced in the design, robustness, qualification/validation and technical transfer of various bioassay platforms in support of large molecule-based biotherapeutics (effector enhanced/ablated mAbs, bi specific mAbs, antibody-drug conjugates, PK-enhanced mAbs, biosuperiors, non-mAb large molecules). Strong track record cross-functional early- and late-clinical stage project success with thorough planning and proactive communication. Broad compliance experience with USP/ICH, and GMP/GLP requirements for multiple assay platforms. Possesses a passion for learning; a high aptitude for detail, organization, and efficiency; and thrives in a fast-paced and intellectually demanding environment. ASSAY TECHNOLOGIES: Varied cell-based potency platforms using primary, rare, transformed, and engineered cell lines Various plate-based platforms, including ELISA, enzymatic assays, DELFIA, Lumit qPCR Immunofluorescent staining and imaging FLOW CYTOMETRY-BASED TECHNOLOGIES: Detailed receptor level and trafficking platforms, phenotyping, cell line characterization MOLECULAR BIOLOGY PIPE/SLIC Cloning Gibson Assembly Restriction Enzyme Digest Primer and plasmid design Transient Transfection INSTRUMENTATION Spectra Max EnVision Amnis Image Stream FACS Canto II LSR-II FACS Scan Guava EasyCyte ViCell Gyros Biacore SOFTWARE EXPERTISE: SoftMax Pro Graph Pad Prism Laser Gene Suite Paws PLA JMP BD FACS Diva FlowJo Excel Amnis INSPIRE Amnis IDEAS Watson LIMS